568 related articles for article (PubMed ID: 19762514)
1. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome.
Besarab A; Hörl WH; Silverberg D
Oncologist; 2009; 14 Suppl 1():22-33. PubMed ID: 19762514
[TBL] [Abstract][Full Text] [Related]
2. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
[TBL] [Abstract][Full Text] [Related]
3. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
Okonko DO; Mandal AK; Missouris CG; Poole-Wilson PA
J Am Coll Cardiol; 2011 Sep; 58(12):1241-51. PubMed ID: 21903058
[TBL] [Abstract][Full Text] [Related]
4. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
Iaina A; Silverberg DS; Wexler D
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
[TBL] [Abstract][Full Text] [Related]
5. The anemia of heart failure.
Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
[TBL] [Abstract][Full Text] [Related]
6. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
Macdougall IC
Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin in heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
[TBL] [Abstract][Full Text] [Related]
8. Intravenous iron, inflammation, and oxidative stress: is iron a friend or an enemy of uremic patients?
Garneata L
J Ren Nutr; 2008 Jan; 18(1):40-5. PubMed ID: 18089442
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in uremia: the role of anemia correction.
Lahera V; Goicoechea M; de Vinuesa SG; Oubiña P; Cachofeiro V; Gómez-Campderá F; Amann R; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S174-7. PubMed ID: 17130258
[TBL] [Abstract][Full Text] [Related]
10. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
Dukkipati R; Kalantar-Zadeh K
Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?
Dahl NV; Henry DH; Coyne DW
Semin Dial; 2008; 21(3):210-1. PubMed ID: 18397204
[TBL] [Abstract][Full Text] [Related]
13. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
14. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.
Fischer MA; Morris CA; Winkelmayer WC; Avorn J
Arch Intern Med; 2007 Apr; 167(8):840-6. PubMed ID: 17452549
[TBL] [Abstract][Full Text] [Related]
15. [Anemia in chronic kidney disease and its cardiovascular implications].
Cases A; Coll E; Collado S
Med Clin (Barc); 2009 May; 132 Suppl 1():38-42. PubMed ID: 19460479
[TBL] [Abstract][Full Text] [Related]
16. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
[TBL] [Abstract][Full Text] [Related]
17. Anemia in renal disease: diagnosis and management.
Lankhorst CE; Wish JB
Blood Rev; 2010 Jan; 24(1):39-47. PubMed ID: 19833421
[TBL] [Abstract][Full Text] [Related]
18. Managing anemia in for-profit dialysis chains: when ethics and business conflict.
Coyne DW
Semin Dial; 2009; 22(1):18-21. PubMed ID: 19250444
[TBL] [Abstract][Full Text] [Related]
19. [Issues related to iron replacement in dialyzed patients].
Kessler M
Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
Singh A
Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
